Research and Markets: Eczema – Pipeline Review, H1 2013

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/z64gwp/eczema_pipeline) has announced the addition of the "Eczema - Pipeline Review, H1 2013" report to their offering.

This report provides information on the therapeutic development for Eczema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Eczema.

Eczema - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Eczema.

- A review of the Eczema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Read more here:
Research and Markets: Eczema - Pipeline Review, H1 2013